Why is Tatva Chintan falling/rising?

As of 01-Aug, Tatva Chintan Pharma Chem Ltd is experiencing a decline in its stock price, currently at Rs 1,118.20, which reflects a decrease of Rs 54.8 or 4.67%. The stock has underperformed its sector by 2.71% today, reaching an intraday low of Rs 1,108, which is a drop of 5.54%. Despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, the stock has seen a significant reduction in investor participation, with delivery volume falling by 23.07% against the 5-day average. Over the past year, the stock has managed to generate a return of 12.44%, outperforming the broader market, which has seen negative returns of 1.55%. The company's low debt-to-equity ratio of 0.07 times and the fact that the majority shareholders are promoters may provide some stability, but these factors have not prevented the recent price decline.
In the broader market context, the stock's short-term performance over the past week shows a decline of 2.51%, while the benchmark Sensex has decreased by only 1.06%. This indicates that Tatva Chintan is underperforming relative to the market. Although the stock has shown positive returns over the longer term, including a 17.71% increase over the past month, the recent downward trend suggests that current market conditions and reduced trading volume are impacting investor sentiment negatively. The overall market has generated negative returns of -4.13% in the last year, yet Tatva Chintan's ability to deliver positive returns during this period highlights its potential, even as it faces short-term challenges.